Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my north star in this crisis is unequivocally patient safety. The "wait for more data" approach is a catastrophic trap—both ethically and legally. History (e.g., Vioxx, Fen-Phen) shows that delaying disclosure of a known severe adverse event transforms a medical safety issue into corporate fraud, manslaughter…Read the full answer
48‑Hour Action Plan (CEO‑Level) Time (UTC) Action Who Leads Key Deliverables / Outcomes Rationale 0–2 h Secure the facts – Convene an emergency “Safety & Compliance” meeting with the Chief Medical Officer (CMO), Chief Legal Officer (CLO), Chief Risk Officer (CRO), and the Head of Regulatory Affairs (RA).Read the full answer